Literature DB >> 28701895

Decreased Serum Concentration of Total IgG Is Related to Tumor Progression in Gastric Cancer Patients.

Hiroaki Saito1, Kozo Miyatani1, Yusuke Kono1, Yuki Murakami1, Hirohiko Kuroda1, Tomoyuki Matsunaga1, Yoji Fukumoto1, Shuichi Takano1, Tomohiro Osaki1, Yoshiyuki Fujiwara1.   

Abstract

BACKGROUND: There is accumulating evidence that shows cell-mediated immunity regulated by T cells is impaired in cancer patients. Unfortunately, the mechanisms by which B cells participate in tumor immunity are only partially understood.
METHODS: The serum concentration of Immunoglobulin G (IgG) was measured by Enzyme-Linked ImmunoSorbent Assay (ELISA) in patients with gastric cancer. Immunohistochemistry was also performed using the anti- cluster of differentiation (CD)134 antibody to evaluate the number of plasma cells in the tumor tissue.
RESULTS: The total serum IgG concentration was significantly lower in patients with lymph node metastasis compared with patients without metastasis. The serum concentration of total IgG at stage III/IV was significantly lower compared with tumors classified as stage I/II. A decreased serum concentration of total IgG and IgG1 was significantly related to a poor prognosis for gastric cancer patients. Furthermore, multivariate analysis indicated that the serum concentration of IgG and lymph node metastasis were independent prognostic indicators for poorer survival. The number of plasma cells was significantly lower in gastric cancer tissue compared with non-cancerous gastric mucosa.
CONCLUSION: A decreased serum concentration of IgG was closely related to poor prognosis, indicating the possibility that impaired antibody-mediated immunity is associated with tumor progression in patients with gastric cancer.

Entities:  

Keywords:  B cell; IgG; gastric cancer; plasma cell; prognosis

Year:  2017        PMID: 28701895      PMCID: PMC5502224     

Source DB:  PubMed          Journal:  Yonago Acta Med        ISSN: 0513-5710            Impact factor:   1.641


  23 in total

1.  Japanese classification of gastric carcinoma: 3rd English edition.

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

2.  Improved survival with ipilimumab in patients with metastatic melanoma.

Authors:  F Stephen Hodi; Steven J O'Day; David F McDermott; Robert W Weber; Jeffrey A Sosman; John B Haanen; Rene Gonzalez; Caroline Robert; Dirk Schadendorf; Jessica C Hassel; Wallace Akerley; Alfons J M van den Eertwegh; Jose Lutzky; Paul Lorigan; Julia M Vaubel; Gerald P Linette; David Hogg; Christian H Ottensmeier; Celeste Lebbé; Christian Peschel; Ian Quirt; Joseph I Clark; Jedd D Wolchok; Jeffrey S Weber; Jason Tian; Michael J Yellin; Geoffrey M Nichol; Axel Hoos; Walter J Urba
Journal:  N Engl J Med       Date:  2010-06-05       Impact factor: 91.245

3.  Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer.

Authors:  Junko Matsuzaki; Sacha Gnjatic; Paulette Mhawech-Fauceglia; Amy Beck; Austin Miller; Takemasa Tsuji; Cheryl Eppolito; Feng Qian; Shashikant Lele; Protul Shrikant; Lloyd J Old; Kunle Odunsi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

4.  Nivolumab and ipilimumab versus ipilimumab in untreated melanoma.

Authors:  Michael A Postow; Jason Chesney; Anna C Pavlick; Caroline Robert; Kenneth Grossmann; David McDermott; Gerald P Linette; Nicolas Meyer; Jeffrey K Giguere; Sanjiv S Agarwala; Montaser Shaheen; Marc S Ernstoff; David Minor; April K Salama; Matthew Taylor; Patrick A Ott; Linda M Rollin; Christine Horak; Paul Gagnier; Jedd D Wolchok; F Stephen Hodi
Journal:  N Engl J Med       Date:  2015-04-20       Impact factor: 91.245

5.  Cell-surface antigens of melanoma recognized by human monoclonal antibodies.

Authors:  H Yamaguchi; K Furukawa; S R Fortunato; P O Livingston; K O Lloyd; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

6.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Authors:  Tyler J Curiel; George Coukos; Linhua Zou; Xavier Alvarez; Pui Cheng; Peter Mottram; Melina Evdemon-Hogan; Jose R Conejo-Garcia; Lin Zhang; Matthew Burow; Yun Zhu; Shuang Wei; Ilona Kryczek; Ben Daniel; Alan Gordon; Leann Myers; Andrew Lackner; Mary L Disis; Keith L Knutson; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

7.  Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer.

Authors:  Giuseppe Perrone; Pier Adelchi Ruffini; Vincenzo Catalano; Cathie Spino; Daniele Santini; Pietro Muretto; Chiara Spoto; Costantino Zingaretti; Valerio Sisti; Paolo Alessandroni; Paolo Giordani; Andrea Cicetti; Silvia D'Emidio; Sergio Morini; Annamaria Ruzzo; Mauro Magnani; Giuseppe Tonini; Carla Rabitti; Francesco Graziano
Journal:  Eur J Cancer       Date:  2008-07-09       Impact factor: 9.162

Review 8.  Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association.

Authors:  Hideaki Shimada; Tamaki Noie; Manabu Ohashi; Koji Oba; Yutaka Takahashi
Journal:  Gastric Cancer       Date:  2013-04-10       Impact factor: 7.370

9.  Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificity.

Authors:  Z Steplewski; L K Sun; C W Shearman; J Ghrayeb; P Daddona; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

Review 10.  Chronic inflammation and cytokines in the tumor microenvironment.

Authors:  Glauben Landskron; Marjorie De la Fuente; Peti Thuwajit; Chanitra Thuwajit; Marcela A Hermoso
Journal:  J Immunol Res       Date:  2014-05-13       Impact factor: 4.818

View more
  4 in total

1.  Deceleration of glycometabolism impedes IgG-producing B-cell-mediated tumor elimination by targeting SATB1.

Authors:  Jiajing Liu; Yifan Li; Zhou Lu; Jie Gu; Yun Liang; Enyu Huang; Zhiming Wang; Hushan Zhang; Luman Wang; Dan Zhang; Hongxiu Yu; Ronghua Liu; Yiwei Chu
Journal:  Immunology       Date:  2018-10-10       Impact factor: 7.397

2.  Immunoglobulin G Subclass-Specific Glycosylation Changes in Primary Epithelial Ovarian Cancer.

Authors:  Marta Wieczorek; Elena Ioana Braicu; Leticia Oliveira-Ferrer; Jahid Sehouli; Véronique Blanchard
Journal:  Front Immunol       Date:  2020-05-15       Impact factor: 7.561

3.  Serum IgG level is a predicting factor for the response to neoadjuvant chemotherapy in patients with esophageal squamous cell carcinoma.

Authors:  Seiichi Nakaya; Ryo Ogawa; Shunsuke Hayakawa; Shiro Fujihata; Tomotaka Okubo; Hiroyuki Sagawa; Tatsuya Tanaka; Hiroki Takahashi; Yoichi Matsuo; Shuji Takiguchi
Journal:  World J Surg Oncol       Date:  2021-07-19       Impact factor: 2.754

Review 4.  The neglected brothers come of age: B cells and cancer.

Authors:  Shabnam Shalapour; Michael Karin
Journal:  Semin Immunol       Date:  2021-06-29       Impact factor: 10.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.